O.T. Pop

Type de document

Co-auteur

O. Hasan Ali

L. Flatz

F. Berner

E.M. Wolfschmitt

J. Walz

D.E. Speiser

S.S. Ring

H.G. Rammensee

M.T. Purde

R. Niederer

J. Neefjes

S. Muller

J. Muller

A Moulin

E. Markert

A. Marcu

J.J. Luimstra

B. Ludewig

T. Lenz

M. Jörger

W. Jochum

A.K. Jochum

T. Hundsberger

S. Haen

T. Gross

M. Früh

L.K. Freudenmann

M.L. Dubbelaar

C. Driessen

S. Diem

A. Cozzio

C. Cicin-Sain

D. Bomze

P. Baumgaertner

J. Bauer

C. Appenzeller

C.J. Ackermann

M.T. Abdou

Date

Source

Serveur académique Lausannois (2)

Mot-clé

thérapie (2) Treatment (2) Inhibitors (2) Tumors (2) Therapeutics (2) T cells (2) Patients (2) Human beings (2) Cancer (2) Use (2) Tumors (2) Patients (2) toxicité (1) tissu (corporel) (1) norme (1) oncologie (1) effet (1) différenciation (1) cancer (1) survie (1) Differentiation (1) Development (1) Cancer (1) Care (1) Identification (1) Antigenic determinants (1) Vaccination (1) Tumors--Immunological aspects (1) Survival (1) Proteins (1)

Documents écrit par O.T. Pop (2) | parle de O.T. Pop (0)

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients.

O. Hasan Ali et al.

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.

F. Berner et al. (2021)